4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-23-073063
Chief Financial Officer sold 5,652 shares at $3.63 ($20,517)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Greenway Schond L. Chief Financial Officer | 2023-12-26 | Sale | −5,652 | $3.63 | $20,517 | 216,617 | D |
| Open-market sales · 5,652 sh · avg $3.63 · $20,517 | |||||||
Loading xslF345X05/ownership.xml…